Supporting this hypothesis, further analysis demonstrated that TRIM31 expression was low in normal colorectal tissues, but progressively increased in inflammatory tissues, precancerous lesions, and colorectal cancer tissues, with significantly higher expression in the latter two. Here, TRIM31 is linked to colorectal cancer.